Presenting at Mid Atlantic Bio Angels’ 1st Pitch Life Science allows early stage life science entrepreneurs to:
- Try out a pitch where no money is immediately at stake
- Hear what investors and audience members think of their presentation and opportunity
- Receive early, constructive feedback from knowledgeable and experienced industry people (including representatives from Mid Atlantic Bio Angels)
- Potentially connect with advisors/mentors and other team members who may be interested in supporting the company’s efforts and adding value at an early stage.
Audience members get to hear how entrepreneurs are pursuing new science and new business opportunities and to provide their own feedback regarding the value and effectiveness of those efforts. The audience votes on a “Best in Show” company which will advance to an annual “Best of the Best/People’s Choice” competition.There is no downside – no investor rejection, no lost opportunities. Just good advice and potential connections that a company can use to improve its strategy and presentation. If you would like to submit an application to present, please fill out an application and return it to email@example.com. We look forward to seeing you there!
Next 1st Pitch in New York: May 25, 2017 at Rockefeller University from 5:30-8:30 pm. Register here.
For the first time ever, there will be a poster session prior to the presentations! The first 10 applications we receive will be guaranteed a poster presentation. All applications will be considered for a pitch presentation. If you are interested in presenting please download an application and return it to firstname.lastname@example.org by Friday, May 12th.
This 1st Pitch event will be preceded by a “meet with investors” roundtable discussion, between 4:30 – 5:30 for academics and entrepreneurs. The investors at the roundtable will discuss the investment process, things to do and to avoid, and things investors look for in an investment opportunity. Select “attending roundtable” option during registration to participate.